polypharmacy | RxISK

What’s a life worth? Is anyone listening?

August 9, 2021 | 17 Comments

This post is by Tracey G. Tracey approached me and as you’ll see others in October 2020 for materials on antidepressants to give her Member of Parliament, Johnny Mercer. She had been in touch in 2018 – “lost in the world of not being taken seriously or believed with regards to a possible protracted withdrawal”. […]

Read more ....

A Public Service or A Lethal Scam?

July 8, 2021 | 19 Comments

RxISK was emailed about a post on SSRI Stories recently. Julie Wood runs SSRI stories, which features newspaper or related public domain material about suicides, homicides or other events linked to SSRI or other psychotropic drug intake. The email read as follows: Your using an article about my family members suicide as a propaganda piece and […]

Read more ....

Clinical Trial Fraud

June 28, 2021 | 13 Comments

This is part two of Johanna Ryan’s posts on Ghosts in the Clinical Trial Machine or Clinical Trial Fraud. Last weeks post reported on how doctors in three states have been convicted of handing in fake clinical-trial results from fake patients. This week we’ll examine how small-time crooks like these ended up doing world-class medical […]

Read more ....

Ghosts in the Clinical Trial Machine

June 21, 2021 | 17 Comments

This is the first part of a two part series on clinical trial fraud from Johanna Ryan, with part 2 next week. Jo is RxISK’s clinical trial and shoddy clinical practice sleuth – see The Maintenance Man. Recently the U.S. Department of Justice called attention to a small but worrisome crime wave. Health care fraud […]

Read more ....

Farewell Marchino

April 30, 2021 | 100 Comments

Nearly a week ago a group of Italians sent this post written after one of their number gave up his struggle with PSSD and the system. We’ve been very slow posting it – partly because of the emotions it stirs. Its quiet beginning and contained fury at the end conjured up Marc Antony’s speech after […]

Read more ....

Antidepressants: Education and Disability Certificates

March 22, 2021 | 38 Comments

This post covers difficulties primarily on antidepressants that medicines can cause to people in schools or universities who end up unable to study or do course-work, as well as the difficulties people can have trying to get off medicines, a process that can be pretty disabling. The materials linked to this post are being put […]

Read more ....

Starship Corona: Captain’s Log

April 26, 2020 | 22 Comments

The use of psychiatric meds in the U.S., already sky-high, is on the rise as a result of Covid-19. That’s not surprising – it happened after the 9-11 attacks, the 2008 crash and other crises. This graph comes from “America’s State of Mind,” an April 2020 report from Express Scripts. In the month from February […]

Read more ....

Covid and the Market in Research

April 13, 2020 | 20 Comments

There are 3 bits to this post – an interview with Joan-Ramon Laporte. An article by Ariane Denoyel and a Q and A with Laporte and Healy. Laporte Interview As part of a series for ROAR Magazine, Frank Barat has run some striking interviews about aspects of the Covid pandemic not usually mentioned. Here […]

Read more ....

Medications compromising Covid Infections

April 2, 2020 | 73 Comments

IN THE MIDST OF THE SARS-CoV-2 PANDEMIA, CAUTION IS NEEDED WITH COMMONLY USED DRUGS THAT INCREASE THE RISK OF PNEUMONIA. Joan-Ramon Laporte, M.D. Emeritus Professor of Clinical Pharmacology, Department of Pharmacology, Therapeutics and Toxicology Universitat Autònoma de Barcelona. Fundació Institut Català de Farmacologia. WHO Collaborating Centre for Research and Training in Pharmacoepidemiology. jrl@icf.uab.cat David Healy […]

Read more ....